Kate Scarlata: The Dietitian Who Made Low-FODMAP Usable

There is a particular kind of expert who arrives late in a story and gets the credit, and another kind who was there at the beginning and spends thirty years doing the unglamorous work of making a thing usable. Kate Scarlata is emphatically the second kind.

The thing, in this case, is the low-FODMAP diet — the most heavily researched dietary approach to irritable bowel syndrome there is, developed by researchers at Monash University in Australia. It works for a lot of people. It is also, in its raw research form, a genuinely difficult protocol to hand a patient: a list of fermentable carbohydrates, a withdrawal phase, a structured reintroduction, and a great many ways to get it wrong. Scarlata is one of the clinicians who turned that into something a person can actually follow on a Tuesday.

The day jobThirty years, one specialty

Scarlata is a Boston-based registered dietitian nutritionist with a master’s in public health and, by her own count, more than thirty years in digestive health. That is an unusual amount of time to spend in one specialty, and it shows in the range: her practice covers IBS, coeliac disease, inflammatory bowel disease, SIBO and mast cell activation syndrome — conditions that overlap, get confused with one another, and are frequently misdiagnosed as each other.

She has been an invited speaker on food intolerance in GI disorders at conferences from Harvard Medical School to Monash, was named best dietitian by Boston magazine, and is a New York Times bestselling author. She is a dietitian rather than a physician, which matters less than it sounds: dietary management of IBS is squarely a dietitian’s territory, and the gastroenterologists who treat it refer to people like her.

The booksFrom protocol to plain English

The bibliography reads like a slow campaign against the same problem. The Complete Idiot’s Guide to Eating Well with IBS came in 2010, 21-Day Tummy in 2013 and its cookbook in 2014, The Low-FODMAP Diet Step by Step in 2017 — each one another attempt to get a research protocol into a form that survives contact with a real kitchen.

The most recent, Mind Your Gut: The Science-based, Whole-body Guide to Living Well with IBS, arrived in March 2024 and is the most interesting of them, because of who she wrote it with. Her co-author is Dr. Megan Riehl, a GI psychologist; the introduction is by Dr. William Chey, one of the more prominent IBS researchers in American gastroenterology. The premise is that diet on its own was never going to be the whole answer for a condition that runs on the gut–brain axis, and that the behavioural half — gut-directed hypnotherapy, cognitive work, the plain fact that stress changes how a gut behaves — belongs in the same book rather than a different one.

She also co-hosts The Gut Health Podcast with Riehl, which is essentially the same collaboration in audio form.

The part that gets left outReintroduction

If there is one message Scarlata has spent years repeating, it is that the low-FODMAP diet is not a diet in the way the internet uses the word. It is a diagnostic process: a short, structured withdrawal to see whether symptoms respond, followed by a deliberate reintroduction to find out which specific triggers actually matter for that individual. The reintroduction is the point. The restriction is only the instrument.

This is not a small distinction. FODMAPs are, in the main, fermentable fibres that feed the gut microbes you want to keep — onion, garlic, wheat, legumes, certain fruits. Staying in the elimination phase indefinitely narrows the diet, and the available research does not support doing it forever. That the message needs repeating at all is a fair summary of what happens when a clinical protocol escapes into social media without its second half attached.

The advocacyBeing believed

Scarlata co-founded #iBelieveinyourStory, a patient-advocacy initiative aimed at something no diet sheet addresses: how routinely people with functional gut disorders are disbelieved. IBS has no visible lesion and no confirmatory scan, which historically made it easy to wave off as anxiety or over-reporting, particularly in women. An adjacent campaign, #EndHungerPain, focuses on the same population.

It is the least commercial thing on her CV and probably the most telling. Thirty years in a specialty where the central complaint is nobody takes this seriously appears to have produced a strong view about who gets believed.

The business of itStandard of care, not a system

The commercial side is straightforward and worth stating: Scarlata has books to sell, a podcast, a private practice and a speaking career. There is no supplement line, and the core of what she recommends — a structured trial, then reintroduction, ideally with a dietitian — is the standard of care rather than a proprietary system. Her site gives away a large amount of the material free, which is its own quiet signal.

The genuinely unusual thing about Scarlata is the patience. Thirty years on one condition, in a field that rewards novelty, and the message has barely changed: this is real, it is manageable, the diet is a tool rather than a life sentence, and you should not have to argue about whether it is happening to you. If your symptoms are new, persistent or changing, that belongs in front of your own doctor first — IBS is a diagnosis made after other things are ruled out, not before. This article is educational, not medical advice.